QI
BIIB icon

Qualcomm Inc’s Biogen BIIB Stock Holding History

Qualcomm Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,500
Closed -$1.06M – 103
2015
Q1 		$1.06M Hold
2,500
– – 0.15% 93
2014
Q4 		$849K Hold
2,500
– – 0.07% 138
2014
Q3 		$827K Hold
2,500
– – 0.06% 138
2014
Q2 		$788K Sell
2,500
-35,400
-93% -$10.7M 0.04% 173
2014
Q1 		$11.6M Hold
37,900
– – 0.59% 42
2013
Q4 		$10.6M Hold
37,900
– – 0.55% 52
2013
Q3 		$9.13M Hold
37,900
– – 0.41% 66
2013
Q2 		$8.16M Buy
+37,900
New +$8.1M 0.33% 71

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Qualcomm Inc's BIIB Position: Q2 2015 in Review

Qualcomm Inc sold out of Biogen (BIIB) in Q2 2015, closing a stake of 2,500 shares — an estimated $1.06M sold.

Qualcomm Inc first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $11.6M in Q1 2014. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

  • Qualcomm Inc reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
  • Qualcomm Inc sold 2,500 Biogen shares in Q2 2015, an estimated $1.06M.
  • Qualcomm Inc first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
  • Qualcomm Inc's Biogen position peaked at $11.6M in Q1 2014.
  • 974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Qualcomm Inc's 13F filing for Q2 2015, filed 13 Aug 2015.